HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Saewon Chun Selected Research

vorasidenib

1/2021Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Saewon Chun Research Topics

Disease

3Glioma (Gliomas)
01/2022 - 01/2021
2Neoplasms (Cancer)
01/2021 - 01/2021
1Glioblastoma (Glioblastoma Multiforme)
01/2021

Drug/Important Bio-Agent (IBA)

1ivosidenibIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1HexokinaseIBA
01/2021
1Oxygen (Dioxygen)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2021
1vorasidenibIBA
01/2021
1Biological ProductsIBA
01/2021

Therapy/Procedure

1Therapeutics
01/2021